Editorial: HBeAg seroconversion is not sufficient to allow cessation of nucleos(t)ide analogue treatment in Caucasian hepatitis B patients

Alimentary Pharmacology&Therapeutics,Volume 47, Issue 11, Page 1551-1552, June 2018.

Source: Alimentary Pharmacology and Therapeutics - May 17, 2018 Category: Drugs & Pharmacology Authors: P. Ingiliz , A. Canbay Source Type: research